Ultrasound-guided percutaneous injection of alcohol. Is it an elective therapy in small diameter nodular hepatocarcinoma associated with cirrhosis?. The authors discuss percutaneous alcohol injection as elective therapy for small hepatocellular carcinoma (less than 5 cm) in liver cirrhosis. Thirteen patients were classified as Child C cirrhosis. Thirty-six months actuarial survival is 60%. These results are similar in patients selected for surgical resection.